Avalo Therapeutics’ $185 Million PIPE

Schulte Roth & Zabel represented Commodore Capital in the transaction.In connection with its acquisition of AlmataBio, Avalo Therapeutics, Inc. issued a PIPE consisting of preferred stock…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now